Cité dans 1 publication.
Cet anticorps anti-BCL3 Polyclonal Lapin (Clone RB23954) (ABIN653286) détecte spécifiquement BCL3 dans WB, IF, FACS et IHC (p).
L’anticorps est réactif avec des échantillons de Humain et Souris.
This BCL3 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 248~277 amino acids from the Center region of human BCL3.
Purification
This antibody is purified through a protein A column, followed by peptide affinity purification.
Immunogène
This BCL3 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 249-277 AA from the Central region of human BCL3.
This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Stock
4 °C/-20 °C
Stockage commentaire
Maintain refrigerated at 2-8 °C for up to 6 months. For long term storage store at -20 °C in small aliquots to prevent freeze-thaw cycles.
Date de péremption
6 months
Gehrke, Wörns, Huber, Hess, Straub, Hövelmeyer, Waisman, Kim, Schuppan, Galle, Schattenberg: "Hepatic B cell leukemia-3 promotes hepatic steatosis and inflammation through insulin-sensitive metabolic transcription factors." dans: Journal of hepatology, Vol. 65, Issue 6, pp. 1188-1197, (2018) (PubMed).
Antigène
BCL3
(B-Cell CLL/lymphoma 3 (BCL3))
Autre désignation
BCL3
Sujet
BCL3 is a proto-oncogene candidate. It is identified by its translocation into the immunoglobulin alpha-locus in some cases of B-cell leukemia. The protein contains seven ankyrin repeats, which are most closely related to those found in I kappa B proteins. This protein functions as a transcriptional co-activator that activates through its association with NF-kappa B homodimers. Synonyms: Proto-oncogene BCL3, B-cell lymphoma 3 protein, BCL-3, D19S37, BCL4, BCL3